Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic cases.

about

Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic cases.

Item

http://www.wikidata.org/entity/Q40980773

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Secondary biopsy of non-oncoge ...... ort of two paradigmatic cases.

@en

type

Item

label

Secondary biopsy of non-oncoge ...... ort of two paradigmatic cases.

@en

prefLabel

Secondary biopsy of non-oncoge ...... ort of two paradigmatic cases.

@en

P1476

Secondary biopsy of non-oncoge ...... port of two paradigmatic cases

@en

P2093

Fausto Barbieri

http://www.w3.org/2001/XMLSchema#string

Federica Bertolini

http://www.w3.org/2001/XMLSchema#string

Filippo Lococo

http://www.w3.org/2001/XMLSchema#string

Giulia Grizzi

http://www.w3.org/2001/XMLSchema#string

Giulio Rossi

http://www.w3.org/2001/XMLSchema#string

Silvia Novello

http://www.w3.org/2001/XMLSchema#string

P2860

Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation.

Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases.

Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?

NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI.

Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study.

A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib.

Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.

P304

359-362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1111/1759-7714.12416

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Cecilia Mengoli

Giulia Orsi

P577

2017-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28383810

http://www.w3.org/2001/XMLSchema#string

P932

5494451

http://www.w3.org/2001/XMLSchema#string